Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 25.93 CNY -5.57% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Beijing Kawin Technology Share-holding Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Kawin Technology Share-holding Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Income from Continuing Operations
ÂĄ137.3m
CAGR 3-Years
25%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Income from Continuing Operations
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Income from Continuing Operations
ÂĄ1.2B
CAGR 3-Years
22%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Income from Continuing Operations
ÂĄ1.8B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
23%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Income from Continuing Operations
ÂĄ6B
CAGR 3-Years
-6%
CAGR 5-Years
26%
CAGR 10-Years
48%
Imeik Technology Development Co Ltd
SZSE:300896
Income from Continuing Operations
ÂĄ1.9B
CAGR 3-Years
62%
CAGR 5-Years
74%
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
44.38 CNY
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
137.3m CNY

Based on the financial report for Dec 31, 2023, Beijing Kawin Technology Share-holding Co Ltd's Income from Continuing Operations amounts to 137.3m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
27%

Over the last year, the Income from Continuing Operations growth was 70%. The average annual Income from Continuing Operations growth rates for Beijing Kawin Technology Share-holding Co Ltd have been 25% over the past three years , 27% over the past five years .

Back to Top